Analysts See $1.10 EPS for ANI Pharmaceuticals, Inc. (ANIP); Cambridge Investment Research Advisors Has Upped By $2.49 Million Its Church & Dwight (CHD) Position

Analysts expect ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) to report $1.10 EPS on May, 3.They anticipate $0.48 EPS change or 77.42% from last quarter’s $0.62 EPS. ANIP’s profit would be $12.90M giving it 13.18 P/E if the $1.10 EPS is correct. After having $1.00 EPS previously, ANI Pharmaceuticals, Inc.’s analysts see 10.00% EPS growth. The stock decreased 1.21% or $0.71 during the last trading session, reaching $57.97. About 44,802 shares traded. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has risen 18.93% since April 28, 2017 and is uptrending. It has outperformed by 7.38% the S&P500.

Cambridge Investment Research Advisors Inc increased Church & Dwight (CHD) stake by 39.22% reported in 2017Q4 SEC filing. Cambridge Investment Research Advisors Inc acquired 49,816 shares as Church & Dwight (CHD)’s stock declined 3.78%. The Cambridge Investment Research Advisors Inc holds 176,825 shares with $8.87M value, up from 127,009 last quarter. Church & Dwight now has $11.42B valuation. The stock increased 1.39% or $0.64 during the last trading session, reaching $46.78. About 1.41 million shares traded. Church & Dwight Co., Inc. (NYSE:CHD) has declined 4.22% since April 28, 2017 and is downtrending. It has underperformed by 15.77% the S&P500.

Among 6 analysts covering ANI Pharma (NASDAQ:ANIP), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. ANI Pharma had 20 analyst reports since July 31, 2015 according to SRatingsIntel. Standpoint Research initiated ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) rating on Friday, November 13. Standpoint Research has “Buy” rating and $54 target. Raymond James initiated the stock with “Strong Buy” rating in Thursday, June 23 report. The firm has “Hold” rating given on Thursday, November 2 by Roth Capital. The company was upgraded on Monday, September 28 by TH Capital. The stock of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has “Outperform” rating given on Friday, July 31 by Oppenheimer. The stock of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has “Buy” rating given on Wednesday, February 28 by Canaccord Genuity. The rating was downgraded by TheStreet on Wednesday, September 2 to “Buy”. The rating was downgraded by TH Capital to “Neutral” on Wednesday, February 22. The stock has “Hold” rating by Standpoint Research on Tuesday, May 24. As per Friday, August 5, the company rating was maintained by Oppenheimer.

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, makes, and markets branded and generic prescription pharmaceuticals in the United States. The company has market cap of $679.86 million. It focuses on producing controlled substances, anti-cancer , hormones and steroids, and complex formulations. It currently has negative earnings. The firm offers Erythromycin Ethylsuccinate to treat infections; Esterified Estrogen with Methyltestosterone for treating vasomotor symptoms of menopause; Etodolac to treat pain caused by osteoarthritis, rheumatoid arthritis, and other conditions; Fenofibrate for treating hypercholesterolemia; Flecainide to treat arrhythmia; Fluvoxamine for treating obsessive-compulsive and social anxiety disorders; and Hydrocortisone Enema and Cortenema to treat ulcerative colitis.

Investors sentiment decreased to 1.09 in Q4 2017. Its down 0.60, from 1.69 in 2017Q3. It dropped, as 13 investors sold ANI Pharmaceuticals, Inc. shares while 43 reduced holdings. 23 funds opened positions while 38 raised stakes. 6.25 million shares or 0.89% less from 6.31 million shares in 2017Q3 were reported. Envestnet Asset Mngmt stated it has 0% of its portfolio in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Moreover, Rhumbline Advisers has 0% invested in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) for 19,789 shares. California State Teachers Retirement holds 12,647 shares or 0% of its portfolio. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0% or 235 shares in its portfolio. Parkside Bancshares & Trust reported 6 shares. Farmers And Merchants Invests reported 131 shares. Citadel Advisors Limited Co holds 6,794 shares. Sg Americas Secs Lc reported 4,815 shares. State Of Alaska Department Of Revenue holds 1,779 shares. Intrust Bancorporation Na has 6,628 shares for 0.13% of their portfolio. Moreover, American International has 0% invested in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). Tiaa Cref Invest Mgmt Lc accumulated 0% or 44,828 shares. 15 are held by Tci Wealth. 61,412 were reported by Inv Counselors Of Maryland Ltd Liability Corp. Chicago Equity Llc reported 0.04% of its portfolio in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP).

Since March 1, 2018, it had 0 insider buys, and 8 insider sales for $11.90 million activity. $120,647 worth of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) was sold by MARSHBANKS TRACY on Wednesday, March 14. RAYNOR DANIEL had sold 27,964 shares worth $1.74M. PRZYBYL ARTHUR had sold 23,986 shares worth $1.47 million. 28,652 shares were sold by Schrepfer Robert W, worth $1.77 million. $258,640 worth of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) shares were sold by Marken James G..

Investors sentiment increased to 0.96 in Q4 2017. Its up 0.01, from 0.95 in 2017Q3. It increased, as 50 investors sold CHD shares while 220 reduced holdings. 67 funds opened positions while 192 raised stakes. 197.64 million shares or 0.87% more from 195.93 million shares in 2017Q3 were reported. Btim holds 0.51% or 696,298 shares. Dorsey And Whitney Tru Ltd Liability Corp holds 14,658 shares. 34,223 are owned by Burns J W & New York. Stephens Inc Ar owns 6,472 shares. M Kraus accumulated 115,408 shares. Bath Savings Trust Com reported 201,320 shares stake. Ubs Asset Mgmt Americas accumulated 1.35M shares or 0.06% of the stock. Laurion Capital Lp reported 23,290 shares. Williams Jones And Assoc Limited Liability reported 0.07% of its portfolio in Church & Dwight Co., Inc. (NYSE:CHD). Gulf Intl Bancorp (Uk) stated it has 0.05% of its portfolio in Church & Dwight Co., Inc. (NYSE:CHD). Aureus Asset Management Lc invested in 4,400 shares. Ls Invest Limited Liability Corporation accumulated 0.03% or 11,223 shares. Ami Asset has 959,278 shares. Arrowstreet Capital LP owns 330,500 shares. Bahl And Gaynor Inc has 263,030 shares.

Among 21 analysts covering Church & Dwight (NYSE:CHD), 4 have Buy rating, 5 Sell and 12 Hold. Therefore 19% are positive. Church & Dwight has $116 highest and $43 lowest target. $60.73’s average target is 29.82% above currents $46.78 stock price. Church & Dwight had 63 analyst reports since July 21, 2015 according to SRatingsIntel. Morgan Stanley maintained Church & Dwight Co., Inc. (NYSE:CHD) rating on Wednesday, February 7. Morgan Stanley has “Underweight” rating and $48 target. Wells Fargo reinitiated Church & Dwight Co., Inc. (NYSE:CHD) on Tuesday, November 15 with “Market Perform” rating. The rating was maintained by Jefferies on Thursday, July 6 with “Buy”. The rating was maintained by BMO Capital Markets on Tuesday, February 6 with “Hold”. The firm has “Market Perform” rating by Wells Fargo given on Tuesday, February 6. As per Wednesday, February 7, the company rating was upgraded by Oppenheimer. On Wednesday, April 19 the stock rating was maintained by Jefferies with “Buy”. The company was maintained on Monday, October 16 by KeyBanc Capital Markets. As per Tuesday, November 7, the company rating was maintained by Barclays Capital. Wells Fargo maintained Church & Dwight Co., Inc. (NYSE:CHD) on Thursday, January 4 with “Hold” rating.

Since February 26, 2018, it had 0 insider buys, and 4 sales for $25.60 million activity. Craigie James sold $3.80 million worth of Church & Dwight Co., Inc. (NYSE:CHD) on Tuesday, February 27. 12,600 shares were sold by KATZ STEVEN J, worth $638,319.

Cambridge Investment Research Advisors Inc decreased Ishares Tr U.S. (IYE) stake by 35,731 shares to 47,833 valued at $1.90 million in 2017Q4. It also reduced Eaton Vance Sr Fltng (EFR) stake by 38,231 shares and now owns 54,121 shares. Disney Walt Co (NYSE:DIS) was reduced too.

Church & Dwight Co., Inc. (NYSE:CHD) Institutional Positions Chart